These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16409143)

  • 21. The promise of new rotavirus vaccines.
    Glass RI; Parashar UD
    N Engl J Med; 2006 Jan; 354(1):75-7. PubMed ID: 16394305
    [No Abstract]   [Full Text] [Related]  

  • 22. Lack of nonspecific protection against all-cause nonrotavirus gastroenteritis by vaccination with orally administered rotavirus vaccine.
    Grant L; Watt J; Moulton L; Weatherholtz R; Reid R; Santosham M; O'Brien K
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):635-40. PubMed ID: 23343932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rotavirus vaccination.
    Bjur KA; Jacobson RM
    Minerva Pediatr; 2009 Oct; 61(5):515-21. PubMed ID: 19794377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New vaccine for infants.
    FDA Consum; 2006; 40(3):3. PubMed ID: 16909482
    [No Abstract]   [Full Text] [Related]  

  • 25. Rotavirus vaccines: an update.
    Dennehy PH
    Curr Opin Pediatr; 2005 Feb; 17(1):88-92. PubMed ID: 15659970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
    Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM
    Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rotavirus vaccine: early introduction in Latin America-risks and benefits.
    Pérez-Vargas J; Isa P; López S; Arias CF
    Arch Med Res; 2006 Jan; 37(1):1-10. PubMed ID: 16314179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
    Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rotavirus vaccines.
    Vesikari T
    Scand J Infect Dis; 2008; 40(9):691-5. PubMed ID: 19086243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life.
    Block SL; Vesikari T; Goveia MG; Rivers SB; Adeyi BA; Dallas MJ; Bauder J; Boslego JW; Heaton PM;
    Pediatrics; 2007 Jan; 119(1):11-8. PubMed ID: 17200266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants.
    Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study.
    Phua KB; Lim FS; Lau YL; Nelson EA; Huang LM; Quak SH; Lee BW; Teoh YL; Tang H; Boudville I; Oostvogels LC; Suryakiran PV; Smolenov IV; Han HH; Bock HL
    Vaccine; 2009 Oct; 27(43):5936-41. PubMed ID: 19679216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rotavirus vaccine trial in Jamaica.
    Christie CD; Duncan ND
    West Indian Med J; 2012 Jul; 61(4):405-7. PubMed ID: 23240476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
    Dennehy PH; Goveia MG; Dallas MJ; Heaton PM
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S36-42. PubMed ID: 18162245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group.
    Rennels MB; Glass RI; Dennehy PH; Bernstein DI; Pichichero ME; Zito ET; Mack ME; Davidson BL; Kapikian AZ
    Pediatrics; 1996 Jan; 97(1):7-13. PubMed ID: 8545227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe.
    Vesikari T; Itzler R; Karvonen A; Korhonen T; Van Damme P; Behre U; Bona G; Gothefors L; Heaton PM; Dallas M; Goveia MG
    Vaccine; 2009 Dec; 28(2):345-51. PubMed ID: 19879226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.
    Goveia MG; Rodriguez ZM; Dallas MJ; Itzler RF; Boslego JW; Heaton PM; DiNubile MJ;
    Pediatr Infect Dis J; 2007 Dec; 26(12):1099-104. PubMed ID: 18043445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.
    Nakagomi T; Cuevas LE; Gurgel RG; Elrokhsi SH; Belkhir YA; Abugalia M; Dove W; Montenegro FM; Correia JB; Nakagomi O; Cunliffe NA; Hart CA
    Arch Virol; 2008; 153(3):591-3. PubMed ID: 18175037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACIP recommends new vaccine to prevent rotavirus. An update from CDC.
    CDC
    Mich Med; 2006; 105(3):20. PubMed ID: 16771161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.